Suppression of cyclooxygenase-2 gene transcription by humulon

Advances in Experimental Medicine and Biology

Volumn 507, Issue , 2002, Pages 73-77

  Yamamoto, Kei ^a   Wang, Jining ^a   Yamamoto, Shozo ^a   Tobe, Hiroyasu ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KOCHI NATIONAL COLLEGE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; HUMULON; PROSTAGLANDIN E2; CYCLOHEXENE DERIVATIVE; DEXAMETHASONE; ISOENZYME; PROSTAGLANDIN SYNTHASE; TERPENE; THYMIDINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; ENZYME SYNTHESIS; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; ANIMAL; CELL STRAIN 3T3; CONSENSUS SEQUENCE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; NUCLEOTIDE SEQUENCE; REVIEW;

ANIMALIA;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CONSENSUS SEQUENCE; CYCLOHEXENES; CYCLOOXYGENASE 2; DEXAMETHASONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ISOENZYMES; MICE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TERPENES; THYMIDINE KINASE; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037769725     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0193-0_12     Document Type: Conference Paper

References (18)

1. H.R. Herschman, Prostaglandin synthase 2, Biochim. Biophys. Acta 1299: 125 (1996).
2. W.L. Smith, R.M. Garavito, and D.L. DeWitt, Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2, J. Biol. Chem. 271:33157 (1996).
3. H. Kodama, Y. Amagai, H. Sudo, S. Kasai, and S. Yamamoto, Establishment of a clonal osteogenic cell line from newborn mouse calvaria, Jpn. J. Oral Biol. 23:899 (1981).
4. H. Sudo, H. Kodama, Y. Amagai, S. Yamamoto, and S. Kasai, In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria, J. Cell Biol. 96:191 (1983).
5. 2 synthesis in cloned osteoblastic cells of mouse (MC3T3-E1) by epidermal growth factor, J. Biol. Chem. 261:15410 (1986).
6. M. Kusaka, T. Oshima, K. Yokota, S. Yamamoto, and M. Kumegawa, Possible induction of fatty acid cyclooxygenase in mouse osteoblastic cells (MC3T3-E1) by cAMP, Biochim. Biophys. Acta 972:339 (1988).
7. T. Oshima, T. Yoshimoto, S. Yamamoto, M. Kumegawa, C. Yokoyama, and T. Tanabe, cAMP-dependent induction of fatty acid cyclooxygenase mRNA in mouse osteoblastic cells (MC3T3-E1), J. Biol. Chem. 266:13621 (1991).
8. Y. Takahashi, Y. Taketani, T. Endo, S. Yamamoto, and M. Kumegawa, Studies on the induction of cyclooxygenase isozymes by various prostaglandins in mouse osteoblastic cell line with reference to signal transduction pathways, Biochim. Biophys. Acta 1212:217 (1994).
9. K. Yamamoto, T. Arakawa, N. Ueda, and S. Yamamoto, Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells, J. Biol. Chem. 270:31315 (1995).
10. C.C. Pilbeam, H. Kawaguchi, Y. Hakeda, O. Voznesensky, C.B. Alander, and L.G. Raisz, Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells, J. Biol. Chem. 268:25643 (1993).
11. H. Tobe, Y. Muraki, K. Kitamura, O. Komiyama, Y. Sato, T. Sugioka, H.B. Maruyama, E. Matsuda, and M. Nagai, Bone resorption inhibitors from hop extract, Biosci. Biotech. Biochem. 61:158 (1997).
12. L.G. Raisz and B.E. Kream, Regulation of bone formation, N. Engl. J. Med. 309:83 (1983).
13. F. Cadepond, A. Ulmann, and E.-E. Baulieu, RU486 (mifepristone): mechanisms of action and clinical uses, Annu. Rev. Med. 48:129 (1997).
14. K. Subbaramaiah, W.J. Chung, P. Michaluart, N. Telang, T. Tanabe, H. Inoue, M. Jang, J.M. Pezzuto, and A.J. Dannenberg, Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells, J. Biol. Chem. 273:21875 (1998).
15. X.-M. Xu, L. Sansores-Garcia, X.-M. Chen, N. Matijevic-Aleksic, M. Du, and K.K. Wu, Suppression on inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate, Proc. Natl. Acad. Sci. USA 96:5292 (1999).
16. P.J. Barnes and I. Adcock, Anti-inflammatory actions of steroids: molecular mechanisms, Trends Pharmacol. Sci. 14:436(1993).
17. H. Inoue, K. Umesono, T. Nishimori, Y. Hirata, and T. Tanabe, Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells, Biochem. Biophys. Res. Commun. 254:292 (1999).
18. H. Inoue and T. Tanabe, Transcriptional role of nuclear factor κB site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells, Biochem. Biophys. Res. Commun. 244:143 (1998).